We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

167 hedge funds and large institutions have $2.37B invested in Agios Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 84 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 34

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

7% more funds holding

Funds holding: 156 → 167 (+11)

1% less capital invested

Capital invested by funds: $2.39B → $2.37B (-$19.4M)

1.34% less ownership

Funds ownership: 97.02% → 95.68% (-1.3%)

38% less call options, than puts

Call options by funds: $11.1M | Put options by funds: $17.9M

43% less funds holding in top 10

Funds holding in top 10: 7 → 4 (-3)

Holders
167
Holders Change
+11
Holders Change %
+7.05%
% of All Funds
4.16%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.1%
New
28
Increased
84
Reduced
34
Closed
16
Calls
$11.1M
Puts
$17.9M
Net Calls
-$6.77M
Net Calls Change
-$3.2M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$45.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$43.7M
3
Invesco
Invesco
Georgia
+$34.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$31.6M
5
BlackRock
BlackRock
New York
+$26M

Top Sellers

1
FP
Flagship Pioneering
Massachusetts
-$56.4M
2
RG
Redmile Group
California
-$11.3M
3
CGT
Capital Guardian Trust
California
-$7.88M
4
GTC
Ghost Tree Capital
New York
-$7.3M
5
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
-$5.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
76
California Public Employees Retirement System
California
$1.8M +$40.9K +800 +2%
GLRA
77
Gerald L. Ray & Associates
Texas
$1.72M -$69K -1,350 -4%
TD Asset Management
78
TD Asset Management
Ontario, Canada
$1.54M +$71.6K +1,400 +5%
OPPM
79
Opus Point Partners Management
New York
$1.52M -$1.43M -27,928 -49%
Lazard Asset Management
80
Lazard Asset Management
New York
$1.52M +$1.51M +29,480 New
HI
81
Handelsinvest Investeringsforvaltning
Denmark
$1.49M +$1.48M +29,000 New
Bank of America
82
Bank of America
North Carolina
$1.47M -$745K -14,568 -34%
UBS AM
83
UBS AM
Illinois
$1.39M +$43.6K +852 +3%
ProShare Advisors
84
ProShare Advisors
Maryland
$1.32M +$122K +2,380 +10%
MOACM
85
Mutual of America Capital Management
New York
$1.25M -$43K -842 -3%
EC
86
EcoR1 Capital
California
$1.2M – – –
Federated Hermes
87
Federated Hermes
Pennsylvania
$1.15M +$774K +15,131 +208%
Group One Trading
88
Group One Trading
Illinois
$1.13M +$515K +10,079 +85%
AllianceBernstein
89
AllianceBernstein
Tennessee
$1.12M +$156K +3,050 +16%
PPA
90
Parametric Portfolio Associates
Washington
$1.05M -$165K -3,237 -14%
PCM
91
Piermont Capital Management
Missouri
$977K -$22.5K -440 -2%
Ohio Public Employees Retirement System (OPERS)
92
Ohio Public Employees Retirement System (OPERS)
Ohio
$944K +$324K +6,338 +53%
CCI
93
Columbus Circle Investors
$908K -$1.29M -25,240 -59%
Creative Planning
94
Creative Planning
Kansas
$860K +$11.7K +228 +1%
PAMU
95
Pictet Asset Management (UK)
United Kingdom
$854K +$107K +2,100 +13%
PA
96
Profund Advisors
Maryland
$822K +$131K +2,558 +19%
VOYA Investment Management
97
VOYA Investment Management
Georgia
$807K +$156K +3,055 +24%
PI
98
Putnam Investments
Massachusetts
$803K +$799K +15,623 New
VKH
99
Virtu KCG Holdings
New York
$743K +$739K +14,449 New
BNP Paribas Financial Markets
100
BNP Paribas Financial Markets
France
$698K +$19.7K +385 +3%
2 3
4
5 6

AGIO Hedge Fund Activity: Q2 2017 in Review

167 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q2 2017, worth a combined $2.37B — down 0.81% from $2.39B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AGIO positions and 16 closed out — a net gain of 12 holders — while 84 added to existing stakes and 34 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $45.8M. The largest seller was Flagship Pioneering, exiting entirely with an estimated $56.4M sold.

  • 167 institutional investors held Agios Pharmaceuticals (AGIO) as of Q2 2017, up from 156 in Q1 2017.
  • Funds reported $2.37B of Agios Pharmaceuticals stock for Q2 2017, down 0.81% quarter-over-quarter.
  • 28 funds opened new Agios Pharmaceuticals positions in Q2 2017 and 16 closed out, a net change of +12 holders.
  • The largest Agios Pharmaceuticals buyer in Q2 2017 was Fidelity Investments, an estimated $45.8M added.
  • The largest Agios Pharmaceuticals seller in Q2 2017 was Flagship Pioneering, an estimated $56.4M sold.

Based on aggregated 13F filings for Q2 2017.